Literature DB >> 9878035

Elevated serum cytokines are associated with cytomegalovirus infection and disease in bone marrow transplant recipients.

A Humar1, P St Louis, T Mazzulli, A McGeer, J Lipton, H Messner, K S MacDonald.   

Abstract

To assess the relationship between serum cytokines and cytomegalovirus (CMV) reactivation, 75 allogeneic bone marrow transplant patients underwent weekly measurements of interleukin (IL)-6, IL-8, and tumor necrosis factor (TNF)-alpha, CMV blood cultures, and antigenemia tests. Of the patients, 44 (58.7%) developed CMV infection, and 19 (25.3%) developed clinical CMV disease. The mean maximum levels of all three cytokines were significantly increased in patients with CMV infection compared with levels in those without. Maximum levels of IL-6 were significantly higher in patients with active CMV disease than in those who did not develop CMV disease (281.2+/-85.5 vs. 95.7+/-15.0 pg/mL; P=.034). Levels of IL-8 and TNF-alpha were also elevated in patients who developed active disease. In a multivariate logistic regression model, IL-6 levels were independently associated with CMV disease (odds ratio=1.70 per 100-pg/mL increase in IL-6; P=.009). Cytokines may play an important role in the pathogenesis of CMV after bone marrow transplantation and may be a useful predictor for CMV.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9878035     DOI: 10.1086/314602

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  32 in total

1.  Variable incidence of cyclosporine and FK-506 neurotoxicity in hematopoeitic malignancies and marrow conditions after allogeneic bone marrow transplantation.

Authors:  Walter S Bartynski; Zella R Zeigler; Richard K Shadduck; John Lister
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

2.  Murine cytomegalovirus dissemination but not reactivation in donor-positive/recipient-negative allogeneic kidney transplantation can be effectively prevented by transplant immune tolerance.

Authors:  Anil Dangi; Shuangjin Yu; Frances T Lee; Melanie Burnette; Jiao-Jing Wang; Yashpal S Kanwar; Zheng J Zhang; Michael Abecassis; Edward B Thorp; Xunrong Luo
Journal:  Kidney Int       Date:  2020-02-21       Impact factor: 10.612

Review 3.  Current Understanding of Cytomegalovirus Reactivation in Critical Illness.

Authors:  Hannah Imlay; Ajit P Limaye
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

4.  Effect of Ganciclovir on IL-6 Levels Among Cytomegalovirus-Seropositive Adults With Critical Illness: A Randomized Clinical Trial.

Authors:  Ajit P Limaye; Renee D Stapleton; Lili Peng; Scott R Gunn; Louise E Kimball; Robert Hyzy; Matthew C Exline; D Clark Files; Peter E Morris; Stephen K Frankel; Mark E Mikkelsen; Duncan Hite; Kyle B Enfield; Jay Steingrub; James O'Brien; Polly E Parsons; Joseph Cuschieri; Richard G Wunderink; David L Hotchkin; Ying Q Chen; Gordon D Rubenfeld; Michael Boeckh
Journal:  JAMA       Date:  2017-08-22       Impact factor: 56.272

5.  Circulating dendritic cells isolated from healthy seropositive donors are sites of human cytomegalovirus reactivation in vivo.

Authors:  Matthew B Reeves; John H Sinclair
Journal:  J Virol       Date:  2013-07-24       Impact factor: 5.103

6.  Chemokines and soluble adhesion molecules in renal transplant recipients with cytomegalovirus infection.

Authors:  I Nordøy; F Müller; K P Nordal; H Rollag; P Aukrust; S S Frøland
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

7.  Human cytomegalovirus and human immunodeficiency virus type-1 co-infection in human cervical tissue.

Authors:  Andrea M Fox-Canale; Thomas J Hope; Jeffrey Martinson; John R Lurain; Alfred W Rademaker; James W Bremer; Alan Landay; Gregory T Spear; Nell S Lurain
Journal:  Virology       Date:  2007-08-22       Impact factor: 3.616

Review 8.  Acceleration of allograft failure by cytomegalovirus.

Authors:  Daniel N Streblow; Susan L Orloff; Jay A Nelson
Journal:  Curr Opin Immunol       Date:  2007-08-22       Impact factor: 7.486

9.  Cytomegalovirus infection in pediatric rheumatic diseases: a review.

Authors:  Eli M Eisenstein; Dana G Wolf
Journal:  Pediatr Rheumatol Online J       Date:  2010-05-20       Impact factor: 3.054

10.  Increased weight loss with reduced viral replication in interleukin-10 knock-out mice infected with murine cytomegalovirus.

Authors:  O R Oakley; B A Garvy; S Humphreys; M H Qureshi; C Pomeroy
Journal:  Clin Exp Immunol       Date:  2007-11-14       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.